Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QDPR | P09417 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4516930 | 0.76 | CHRM3 (0.54) | QDPRLMNACHRM2CHRM4CHRM5 | |
| SCHEMBL3579440 | 0.76 | TRPV1 (0.49) | KMT2ALMNA | |
| SCHEMBL1971079 | 0.75 | CYP2C9 (0.42) | ALDH1A1LMNACHRM2CHRM4CHRM5 | |
| SCHEMBL2226831 | 0.74 | CHRM2 (0.61) | LMNACHRM2CHRM4CHRM5THRB | |
| Hydrochloric Acid SCHEMBL10419893 | 0.73 | CYP2C9 (0.41) | ALDH1A1KMT2ALMNACHRM2CHRM4 | |
| SCHEMBL3841650 | 0.73 | QDPR (0.43) | QDPRLMNABLM | |
| SCHEMBL1538433 | 0.73 | QDPR (0.43) | QDPR | |
| SCHEMBL13183420 | 0.73 | HDAC4 (0.44) | ALDH1A1KMT2ALMNACHRM2CHRM4 | |
| SCHEMBL11887371 | 0.72 | QDPR (0.42) | QDPR | |
| SCHEMBL9203433 | 0.72 | QDPR (0.42) | QDPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797889-A1 | NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS | Centaurus Biopharma Co., Ltd. (CN) | 2014-11-05 | — | — | EP | disclosed |
| WO-2013097773-A1 | NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS | CENTAURUS BIOPHARMA CO., LTD. (CN) | 2013-07-04 | — | — | WO | disclosed |
| EP-0537993-A1 | Nicotinic activity of a series of arecolones and isoarecolones | ELI LILLY AND COMPANY (US) | 1993-04-21 | — | — | EP | disclosed |